The mushrooms that produce a “high” or psychedelic experience almost all belong to the genus Psilocybe, which contains the active compound psilocybin. There are over 200 known species in this group, but only a handful are commonly encountered or cultivated. One other well-known mushroom, the red-and-white fly agaric (Amanita muscaria), produces psychoactive effects through an entirely different mechanism and is often confused with psilocybin mushrooms despite having little in common with them chemically.
Psilocybe Cubensis: The Most Common Species
Psilocybe cubensis is the most widely recognized and cultivated psilocybin mushroom in the world. It grows naturally in tropical and subtropical climates on the dung of cows and horses, and it’s preferred by growers because it thrives on simple substrates, produces large fruiting bodies, and is relatively easy to cultivate even outside a lab. When people refer to “magic mushrooms” or “shrooms,” they’re almost always talking about this species or one of its many cultivated strains.
Psilocybin content in cubensis ranges from about 0.01% to 1.35% of dry weight, which means potency can vary dramatically from one batch to another. This is one reason experiences can feel unpredictable even with the same species.
Other Potent Psilocybe Species
Several other Psilocybe species are well known for their psychoactive properties, and some are significantly stronger than cubensis.
- Psilocybe semilanceata (liberty caps): Small, bell-shaped mushrooms that grow in grassy meadows across Europe and North America. Psilocybin content reaches up to 1.70% of dry weight, making them pound-for-pound among the most potent species. Their tiny size means you need more individual mushrooms, but less total material.
- Psilocybe azurescens: Found in the Pacific Northwest of the United States, this species holds some of the highest recorded psilocybin levels, up to 1.78% by dry weight. It grows on wood chips and coastal dune grasses.
- Psilocybe cyanescens (wavy caps): Also a wood-chip grower common in the Pacific Northwest and parts of Europe, with psilocybin content up to 1.84%. Recognizable by the wavy, undulating edges of its cap.
All psilocybin-containing mushrooms share one visible trait: they bruise blue or greenish-blue when handled or damaged. This bluing reaction is caused by the oxidation of psilocin and is one of the quickest ways to distinguish them from non-psychoactive species.
How Psilocybin Works in the Body
Psilocybin itself isn’t actually what gets you high. It’s a prodrug, meaning your body has to convert it before it becomes active. After you eat the mushrooms, enzymes in your gut strip a phosphate group off psilocybin, turning it into psilocin. Psilocin is the molecule that crosses into the brain and binds to serotonin receptors, particularly one called 5-HT2A. By activating these receptors, psilocin disrupts normal patterns of brain communication, which produces the characteristic shifts in perception, emotion, and sense of self.
Psilocybin mushrooms also contain smaller amounts of related compounds like baeocystin and aeruginascin. Some people speculate these contribute to differences in experience between species, but lab testing in mice has shown that baeocystin and aeruginascin don’t appear to produce psychedelic-like effects on their own. The role they play, if any, remains unclear.
What the Experience Feels Like
Effects typically begin 30 to 60 minutes after eating the mushrooms. The peak hits somewhere between 90 minutes and 3 hours in, then gradually tapers off. Most people feel back to baseline within 6 to 7 hours, though a sense of emotional openness or mental clarity can linger longer.
During the peak, you may see vivid colors, geometric patterns, or shifting shapes. Sounds can feel amplified or distorted. Many people describe a warped sense of time, where minutes feel like hours. Emotions become intensified, sometimes swinging between deep joy and sudden anxiety within the same experience. At higher doses, people report a dissolving of personal boundaries, a feeling of merging with the environment or “becoming one with the universe.” This can be deeply meaningful or profoundly disorienting depending on the person and setting.
Physical effects include increased heart rate, elevated blood pressure, nausea (especially during the onset), and dilated pupils. Nausea is one of the most common complaints and is sometimes severe enough to cause vomiting. Agitation, confusion, and panic can occur, particularly in uncomfortable environments or at unexpectedly high doses. This is what’s commonly called a “bad trip.”
Fly Agaric: A Different Kind of Mushroom
Amanita muscaria, the iconic red mushroom with white spots, is psychoactive but works through a completely different system than psilocybin mushrooms. Its active compound is muscimol, which acts on GABA receptors in the brain rather than serotonin receptors. GABA is the brain’s main calming neurotransmitter, so the effects of muscimol are more sedative and deliriant than classically psychedelic.
People who consume fly agaric report euphoria, dizziness, altered sensory perception, and dreamlike hallucinations, but the experience tends to feel heavier and more disorienting than psilocybin. The raw mushroom also contains ibotenic acid, a toxic precursor to muscimol that converts when the mushroom is dried or heated. This reduces toxicity but doesn’t eliminate risk. Despite growing interest in fly agaric as a “natural” alternative to psilocybin, its effects are not comparable, and the tendency to treat these mushrooms as interchangeable reflects a common misconception.
Dangerous Lookalikes
One of the most serious risks with psychoactive mushrooms isn’t the mushrooms themselves but misidentification. Many psilocybin species are small, brown, and nondescript, making them easy to confuse with toxic species that share the same habitats.
The most dangerous lookalike is Galerina marginata, a small brown mushroom that contains amatoxins capable of destroying the liver and kidneys. It grows on wood chips, the same substrate favored by Psilocybe cyanescens and other wood-loving species. Telling them apart requires careful attention. Psilocybe species produce dark purplish-brown spore prints, while Galerina species leave rusty brown or cinnamon-brown prints. Psilocybe mushrooms bruise blue on the stem and cap edges. Galerina stems turn blackish with age, never blue. The distinction matters enormously: confusing black for blue on a stem can be fatal.
Galerina also tends to have a more distinct fibrous ring on the stem, and its cap does not develop the wavy edges characteristic of species like Psilocybe cyanescens. If there is any doubt about identification, a spore print is the single most reliable field test.
Legal Status
Psilocybin remains a Schedule I controlled substance in the United States at the federal level, meaning possession and sale carry criminal penalties. However, the FDA has granted “breakthrough therapy” designation to two psilocybin formulations being studied as treatments for depression, which allows the research process to move faster. Several cities and states have moved to decriminalize possession or allow supervised therapeutic use, though the legal landscape varies widely and continues to shift. Amanita muscaria occupies a legal gray area in many jurisdictions, as muscimol is not specifically scheduled in most countries the way psilocybin is.